Christina Harview is a Dermatology physician. OpenAlex indexes 41 publications with 8,929 citations (h-index 11). By OpenAlex citation count, this profile ranks in the top 5% of Dermatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1331 N 7th St Ste 250
Phoenix, AZ 850062722
Telephone
602-483-6504Provider last certified this registry record 3 Oct 2022.
Industry payments
28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Galderma Laboratories, L.P.Program year202531 payments
- Incyte CorporationProgram year202515 payments
- ABBVIE INC.Program year202518 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
25.9%Azole Antifungal14.7%Ketoconazole100%Part D≥61 patientsTetracycline-class Drug5.3%Doxycycline Hyclate100%Part D≥23 patients+ 2 more classes in this area
Sensory organs
20.3%Corticosteroid20.3%Clobetasol Propionate62%Hydrocortisone38%Part D≥46 patientsCancer & immunology
16.7%Calcineurin inhibitor4.9%Tacrolimus100%Part D≥21 patientsRetinoid3.8%Tretinoin100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Use of ancillary studies in pediatric spitzoid neoplasms: A retrospective cohort study
Journal of the American Academy of Dermatology
2026 - 124 Roflumilast as an Emerging Treatment for Oral Lichen Planus: A Case Series
Journal of Investigative Dermatology
2025 - 64728 Oral Lichen Planus and Apremilast: Case Series and Literature Review
Journal of the American Academy of Dermatology
2025 - Pilomatricoma on the Abdomen with Overlying Striae Distensae: A Unique Presentation
SKIN The Journal of Cutaneous Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”